Microbix renegotiates Chinese vax plant deal; Sanofi Pasteur typhoid vax receives prequalification from WHO;

Vaccine Research

Researchers have found that an accelerated hepatitis B vaccination schedule was effective and well tolerated in at-risk pregnant women. The three shots were give in 12 weeks, instead of the usual six months. Story

Vaccine Market

Microbix Biosystems and Hunan Biopharmaceutical are renegotiating key terms in their joint venture agreement to create Asia's largest flu vaccine production facility. The talks come after Microbix closed Phase I financing for its subsidiary Crucible and Hunan expressed interest in altering portions of the agreement. Microbix release

Sanofi Pasteur has received a prequalification from the World Health Organization for its polysaccharide typhoid vaccine, Typhim Vi. It's the first typhoid vaccine to receive the status. Item

Annapolis, MD-based PharmAthene reached a technical milestone in its recombinant protective antigen anthrax vaccine program by finishing the initial technology transfer of its SparVax manufacturing process. PharmAthene release

And Finally... A study found that Amish parents who refuse to vaccinate their children are driven by the same reasons as non-Amish parents, rather than their religious beliefs. In Holmes County, OH, 49 unvaccinated families responded to a survey and stated they didn't feel vaccines were worth the risks, rather than a matter of access to the vaccines. Report

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.